返回
Creative Medical Technology Holdings Inc（CELZ）價格
CELZ 股價走勢圖
CELZ 財務
Creative Medical Technology Holdings Inc
$0
0%
$0
截至今日：Feb 17, 12:49:55 GMT-5
收入
資產負債表
現金流量
年度
每季
CELZ 收入
財務數據以百萬美元計。會計年度為二月至一月。
Follow-Up Questions
Creative Medical Technology Holdings Inc 的關鍵財務報表是什麼？
CELZ 的關鍵財務比率是什麼？
Creative Medical Technology Holdings Inc 的收入按細分市場或地理位置如何劃分？
Creative Medical Technology Holdings Inc 是否盈利？
Creative Medical Technology Holdings Inc 有負債嗎？
Creative Medical Technology Holdings Inc 的流通股有多少？
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
103.3K
每股盈餘 (TTM)
-2.87
股息收益率
--
市值
--
什麼是 CELZ？
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona and currently employs 4 full-time employees. The company went IPO on 2009-05-01. The firm conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.